SUMMARY
It is now well established that bupivacaine-induced cardiotoxicity (cardiac arrest, cardiovascular collapse, bradycardia, atrioventricular and intraventricular blocks, ventricular arrhythmias) is caused mainly by a marked inhibition of cardiac sodium channels [1] and depression of myocardial contractility [2] . The inhibition of cardiac sodium channels is responsible for a decrease in the maximal upstroke velocity (Fmax) of fast action potentials [1] with a dramatic decrease in atrial and ventricular conduction velocities [3, 4] . In vivo, the decrease in conduction velocity is responsible for bradycardia, PR lengthening with atrio-His (AH) interval and even more His-ventricle (HV) interval alterations, and QRS widening [5] [6] [7] . Moreover, bupivacaine prolongs ventricular effective refractory period [4] and therefore prolongs QT interval in vivo [6, 7] . Finally, all these alterations facilitate arcs of functional conduction blocks which explain the occurrence of re-entrant arrhythmias reported previously [4, 8, 9] .
Bupivacaine-induced cardiotoxicity is difficult to treat [8, 10] . Thus many experimental studies have been designed to find the best drug to resuscitate cardiotoxic accidents after control of both hypoxia and convulsions [11] [12] [13] [14] [15] . We have previously described in anaesthetized dogs that clonidine reversed the impairment of ventricular conduction induced by bupivacaine [16] . However, the mechanism of action of clonidine is unknown.
Lemakalim, the active enantiomer of cromakalim, is an ATP potassium channel opener [17] . It induces arteriolar vasodilatation [18] [19] [20] [21] [22] , shortens duration of the action potential and restores Fmax in cardiac cells previously depolarized, by inducing a more negative maximum diastolic potential [23] . Bupivacaine has opposite in vitro electrophysiological effects. Indeed, bupivacaine induces less negative maximum diastolic potential [24] and decreases the Fmax of fast action potentials by specifically blocking the cardiac sodium channels in their inactivated states [1] . In other words, the more prolonged the action potential duration, the greater the inhibition of cardiac sodium channels caused by bupivacaine. We may hypothesize that lemakalim could restore the Fmax of action potential after exposure to bupivacaine by inducing a more negative maximum diastolic potential, a shorter action potential duration, or both. In this way, lemakalim could therefore normalize the in vivo ECG alterations induced by a large dose of bupivacaine. Moreover, in our laboratory we observed, in vivo in anaesthetized dogs, that lemakalim shortens indices of ventricular conduction and repolarization and the ventricular effective refractory period [unpublished observations].
As large doses of bupivacaine prolong PR, AH, HV and QT intervals, and widen QRS complexes, and as lemakalim has opposite effects, we have studied the effects of lemakalim in anaesthetized dogs given a large dose of bupivacaine.
MATERIAL AND METHODS

Animal preparation
The principles for the care and treatment of experimental animals complied with the national guidelines of the French Ministry of Agriculture. We used an experimental electrophysiological model of closed-chest dogs anaesthetized with sodium pentobarbitone [25, 26] . Twelve mongrel dogs of both sexes, weights 10-15 kg, were anaesthetized with sodium pentobarbitone 40 mg kg" 1 i.v. The trachea was intubated and the lungs ventilated mechanically with room air (74052, B. Braun, Melsungen, Germany). Body temperature was maintained at 38 + 0.5 °C with an MR 450 rewarming humidifier device (Fisher and Paykel Ltd, Auckland, New Zealand). We have demonstrated previously that each measured variable in this anaesthetized model remains stable over the duration of the study [7, 16] .
The animals were instrumented as described previously [27] . ECG recordings were taken from standard lead II. A 6-French gauge bipolar electrode catheter (USCI, C. R. Bard, Inc., Billerica, MA, U.S.A.) was introduced via the femoral vein under fluoroscopy into the right ventricle, close to the interventricular septum near the tricuspid valve to record the His-bundle electrogram [26] . Drugs were administered via a 6-French gauge venous catheter in the contralateral femoral vein. A 5-French gauge Teflon catheter (Plastimed, Saint Leu la Foret, France) was inserted into the femoral artery and advanced into the descending aorta to sample arterial blood for measurement of blood-gas tensions (pH > 7.35, Pa O] , > 11.5 kPa, Pa COi , < 5.3 kPa) (Instrument Laboratory 1306 pH/blood gas analyzer, Italy), and for the assay of plasma concentrations of bupivacaine. The contralateral femoral artery was cannulated with a 6-French gauge double high fidelity micromanometer (Millar Instruments, Houston, TX, U.S.A.) advanced into the left ventricle under fluoroscopy to measure left ventricular and aortic pressures. The procedure of animal preparation required about 30 min.
Measurements
The following electrophysiological measurements (expressed in ms) were made: cardiac cycle duration (R-R interval); PR interval measured from the onset of the P wave to the Q wave of the QRS complex; AH interval measured from the onset of atrial depolarization to the His-bundle electrogram of the endocavitary lead; HV interval measured from the His-bundle electrogram of the endocavitary lead to the Q wave of ECG lead II; QRS duration. The indices of ventricular repolarization were QT interval corrected by R-R interval (QTcorr. = QT/v/R-R 5 Bazett formula) and JT interval measured from the end of QRS to the end of T wave corrected by R-R interval (JTcorr. = JT/\/R-R). The following haemodynamic variables were measured: mean aortic pressure (MAoP, mmHg); left ventricular end-diastolic pressure (LVEDP, mm Hg); peak of the first derivative of left ventricular pressure (LVdP/dmiax, mm Hg s" 1 ) as an index of contractility [28] derived with a Gould differentiator. All these variables were recorded on an ES 1000 polygraph (100 mm s" 1 ) (Gould Inc., Oxnard, CA, U.S.A.). The plasma concentration of bupivacaine was measured by high pressure liquid chromatography [29] [30] [31] .
Experimental procedure
We studied two groups of six dogs. In each animal, a 30-min period was allowed for stabilization of the preparation. Each animal was then given atropine 0.2 mg kg" 1 i.v. to prevent vagal reactivity; this dose has been demonstrated to inhibit completely any cardiac response to stimulation of the cervical vagus nerves in our preparation and in another study [32] . As described previously, atropine does not modify the electrophysiological and mechanical changes induced by bupivacaine [33] .
All dogs also received saline solution 3.5 ml kg" 1 h" 1 i.v. and bupivacaine 4 mg kg" 1 i.v. (Bupivacaine HC1 0.5 %, Laboratoires R. Bellon, Neuillysur-Seine, France) over 10 s, 5 min after the atropine injection. We have reported previously that this dose of bupivacaine induces marked myocardial depression and major electrophysiological changes without causing cardiovascular collapse or immediate cardiac death [6] . Dogs in group 1 received bupivacaine only; those in group 2 received, 1 min after the bupivacaine, lemakalim 0.03 mg kg" 1 i.v. (provided by SmithKline Beecham Laboratoires Pharmaceutiques, Unite de Recherche, St-Gregoire, France) over 1 min period.
Electrophysiological and haemodynamic variables were recorded before and 5 min after administration of atropine (just before bupivacaine administration (0 min: baseline)), and 1,2,3,4, 5,10,15 and 30 min after the bupivacaine administration. Arterial blood samples were obtained before and at the end of the bupivacaine injection, and 3, 15 and 30 min later.
Statistical analysis
Results are expressed as mean (SD). The effects of atropine in the two groups, the effects of bupivacaine throughout the study in group 1 and at time 1 min in group 2 were tested using one-way ANOVA for repeated measures, followed by contrast study and completed with Bonferroni's correction [34] . Data from group 2 were compared with those of group 1 to compare the effects of bupivacaine between the two groups at time 1 min, and then to test the effects of lemakalim using two-way ANOVA for repeated measures, followed by contrast study and completed with Bonferroni's correction [34] . P < 0.05 was considered statistically significant. All the results were analysed on a micro Vax II computer (Digital Equipment Corporation, Maynard, MA, U.S.A.) with a 1990 version 6 SAS computer program (SAS Institute Inc., Cary, NC, U.S.A.). 
RESULTS
Atropine did not significantly modify the electrophysiological and haemodynamic variables in the two groups (tables I, II). In group 1, bupivacaine induced non-significant bradycardia, a greater than 50% increase in PR interval (P < 0.001 at 1 min; P < 0.01 from 2 to 5 min; P < 0.05 at 10 min) and a non-significant increase in AH interval. Bupivacaine prolonged the HV interval by more than 100 % (P < 0.001 from 1 to 5 min; P < 0.01 at 10 and 15 min) ( fig. 1) , caused a widening (> 100%) of the QRS complex (P < 0.01 at 1 and 2 min; P < 0.05 from 3 to 10 min), and prolonged the QTcorr. interval (P < 0.05 from 1 to 15 min) (table I) . Similarly, bupivacaine impaired the haemodynamic state: it decreased LVdP/drmax (P < 0.05 from 1 to 10 min) and increased LVEDP (P < 0.05 from 1 to 4 min) by more than 50%. Bupivacaine decreased MAoP (ns). Similar effects of bupivacaine were observed in group 2 at 1 min before administration of lemakalim.
Lemakalim did not modify R-R and AH intervals (table I). In contrast, the increase in PR interval induced by bupivacaine was significantly improved by lemakalim. Lemakalim significantly and quickly reversed the increase in HV interval and the QRS widening induced by bupivacaine ( fig. 1 ) and corrected the alterations in QTcorr. and JTcorr. induced by bupivacaine (table I) . Although MAoP decreased more in group 2, lemakalim did not significantly modify the haemodynamic alterations induced by bupivacaine (table II) .
All bupivacaine plasma concentrations were in the toxic range from the end of bupivacaine administration to 15 min. There was no significant difference between the two groups (table III) . 
DISCUSSION
We have shown that lemakalim corrected the electrophysiological disturbances induced by bupivacaine on atrio-ventricular conduction, conduction and repolarization of ventricles. The dose of bupivacaine 4 mg kg" 1 we used induced alterations similar to those reported elsewhere [5] [6] [7] 9, [12] [13] [14] [15] [16] . Moreover, plasma concentrations of bupivacaine were in the toxic range-that is, they exceeded 2 ug ml" 1 -from the end of bupivacaine injection to 15 min [10] . Therefore, we can assume that our model is suitable for studying in vivo bupivacaine cardiotoxicity.
HV interval and QRS duration were impaired dramatically by bupivacaine. HV interval and QRS duration are known to be correlated with the His-Purkinje system and ventricular conduction velocities, respectively [26, 35] . As lemakalim normalized HV interval and QRS duration after bupivacaine administration, our results suggest that lemakalim restored these conduction velocities. Moreover, the main mechanism of ventricular arrhythmias induced by local anaesthetics and by class lb and lc antiarrhythmic drugs is slowing of ventricular conduction velocity, inducing arcs of functional conduction blocks with re-entry phenomena around them [4, 36, 37] . Indeed, using ventricular mapping in anaesthetized dogs, Anderson and co-workers [37] demonstrated that ventricular tachycardias are induced with large plasma concentrations of lignocaine. These authors also reported that activation patterns obtained just before the onset of ventricular tachycardias simultaneously showed marked slowing of ventricular conduction velocity and QRS widening [37] . Using left ventricular epicardial mapping in rabbit hearts, we have demonstrated previously that bupivacaine markedly slows ventricular conduction velocity and induces re-entrant arrhythmias around the functional arcs of conduction blocks [4] . Therefore, as lemakalim improved bupivacaine-induced QRS widening and HV prolongation, we postulate that lemakalim may prevent the occurrence of re-entrant ventricular arrhythmia induced by a toxic dose of bupivacaine.
Lemakalim also reversed alterations in ventricular repolarization induced by bupivacaine. Indeed, the prolongation of QTcorr. and JTcorr. intervals was corrected quickly by administration of lemakalim. Kasten [38] studied anaesthetized dogs and suggested that ventricular arrhythmias induced by bupivacaine are similar to torsades de pointes. This author reported that the occurrence of torsades de pointe was facilitated by QT prolongation and refractoriness dispersion induced by bupivacaine [38] . Thus we may postulate also that lemakalim might protect against the occurrence of this type of arrhythmia after bupivacaine-induced cardiotoxicity. Moreover, some in vitro and in vivo studies have demonstrated that potassium channel openers are efficient antiarrhythmic drugs when repolarization is delayed [39] [40] [41] [42] .
Different mechanisms might be involved in the beneficial effects of lemakalim in the reversal of bupivacaine-induced cardiotoxicity. Correction of the prolongation of ventricular repolarization seems to be clear, because potassium channel openers or the activation of ATP potassium current decreases the duration of action potentials [23, [43] [44] [45] [46] . In contrast, the improvement in ventricular conduction induced by lemakalim after administration of bupivacaine remains unclear. One could suggest that lemakalim increases the Fmax of fast action potentials by inducing hyperpolarization [47] . However, no study has reported that potassium channel agonists induce hyperpolarization associated with an increase in Fmax, except in cardiac cells partially depolarized by ischaemia [23, 48] . Our dogs were believed not to have myocardial ischaemia. However, it has been reported that bupivacaine depolarizes the cardiac membrane potential [24] , therefore we may postulate that lemakalim restores a more negative maximum diastolic potential and corrects the dramatic decrease in Fmax induced by bupivacaine. Another mechanism could be involved. Clarkson and Hondeghem [1] demonstrated that bupivacaine preferentially blocks cardiac sodium channels during diastole in their inactivated states. As lemakalim decreases the duration of action potentials, it could be postulated that lemakalim decreases block of cardiac sodium channels in their inactivated states and therefore lemakalim could restore Fmax. However, our in vivo model did not permit confirmation of these hyp-otheses. Further studies are therefore required to elucidate the mechanisms responsible for lemakaliminduced shortening of HV and QRS in anaesthetized dogs given a large dose of bupivacaine.
The increase in PR interval induced by bupivacaine was corrected by lemakalim because the HV interval was decreased, while the AH interval was not modified. In addition, there was no worsening of heart rate or other haemodynamic variables. Thus it appears that lemakalim is more efficient than clonidine in reversing bupivacaine cardiotoxicity. Indeed, clonidine also improves ventricular conduction in anaesthetized dogs, but enhances bradycardia, does not modify the PR interval because it prolongs the AH interval, and tends to worsen the haemodynamic depression induced by bupivacaine [16] . Nevertheless, care must be taken before extrapolating these results to the clinical setting. It must be emphasized that the dogs were anaesthetized and received atropine. In addition, the beneficial effects of lemakalim were observed in dogs that had suffered neither cardiovascular collapse nor ventricular arrhythmias. In contrast, the clinical resuscitation of cardiotoxic accidents necessitates oxygenation, treatment of convulsions and specific cardiac resuscitation [10] , which requires simultaneous correction of electrophysiological and haemodynamic disturbances [16] . Indeed, despite the production of little cardiovascular change in our study, it must be emphasized that lemakalim or other ATP potassium channel openers induce arteriolar vasodilatation. In the absence of catecholamines, their use may therefore precipitate cardiovascular collapse after bupivacaine overdosage. Furthermore, except in the case of delayed repolarization induced by drugs such as bupivacaine, the use of lemakalim or of other ATP potassium channel openers may facilitate arrhythmias [49, 50] .
